STIFEL FINANCIAL CORP

Position in VSTM — Verastem, Inc.

CIK 720672 ST. LOUIS, MO

Position in VSTM

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$206,121

-$100,918 QoQ

Shares Held

38,891

-2.2% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 2.2370214188372635.ToString("F0")% Shared 0.ToString("F0")% None 97.76297858116274.ToString("F0")%

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. VSTM ranks #82 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BHVN	Biohaven Ltd.	9,940,885	$84,099,887
2	VRTX	Vertex Pharmaceuticals Inc / Ma	161,052	$71,916,158
3	REGN	Regeneron Pharmaceuticals, Inc.	48,907	$37,787,502
4	JAZZ	Jazz Pharmaceuticals plc	139,514	$26,375,120
5	OMER	Omeros Corp	1,831,585	$19,341,536
6	MANE	Veradermics, Inc	294,117	$18,573,488
7	ALNY	Alnylam Pharmaceuticals, Inc.	49,954	$16,528,277
8	IONS	Ionis Pharmaceuticals Inc	196,703	$14,770,427

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$206,121	38,891	-2.2%	Shares	Defined	2026-05-12
2025-12-31	$307,039	39,772	-5.5%	Shares	Defined	2026-02-13
2025-09-30	$371,723	42,098	+0.3%	Shares	Defined	2025-11-12
2025-06-30	$174,166	41,968	+0.7%	Shares	Defined	2025-08-14
2025-03-31	$251,214	41,661	+5.2%	Shares	Defined	2025-05-14
2024-12-31	$204,694	39,593	+30.5%	Shares	Defined	2025-02-13
2024-09-30	$90,712	30,339	+62.3%	Shares	Defined	2024-11-14
2024-06-30	$55,716	18,697	+8.1%	Shares	Defined	2024-08-13
2024-03-31	$204,175	17,303	-1.5%	Shares	Defined	2024-05-14
2023-12-31	$143,019	17,570	+41.0%	Shares	Defined	2024-02-12
2023-09-30	$101,307	12,461	-21.5%	Shares	Defined	2023-11-13
2023-06-30	$118,043	15,866	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.